Sun Pharma Advanced Research Co (BOM:532872) Valuation Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:532872 Sun Pharma Advanced Research Co Ltd BOM:532872
44 GF Score
Price ₹235.25
GF Value ₹83.76
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Sun Pharma Advanced Research Co Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Sun Pharma Advanced Research Co Valuation Rank Related Terms

BOM:532872
44GF Score
Sun Pharma Advanced Research Co Ltd BOM:532872
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Sun Pharma Advanced Research Co (BOM:532872) Overvalued in 2026?

Based on GuruFocus' analysis, Sun Pharma Advanced Research Co stock appears to be overvalued. The current stock price of ₹235.25 is trading 180.9% above its estimated GF Value™ of ₹83.76. GuruFocus considers Sun Pharma Advanced Research Co to be Significantly Overvalued.

Key valuation signals for BOM:532872:

  • Valuation Rank:
  • GF Value™: ₹83.76 vs. price of ₹235.25 (180.9% above fair value)
  • GF Score™: 44/100 with 5 warning signs

No single metric tells the full story. See the BOM:532872 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sun Pharma Advanced Research Co Business Description

Other Exchanges SPARC:India
Address Off Mahakali Caves Road, 17-B, Mahal Industrial Estate, Andheri (East), Mumbai, MH, IND, 400093
Sun Pharma Advanced Research Co Ltd is an Indian specialty and generic drug manufacturing company. The company has identified pharmaceuticals research and development as its only reportable segment. The company is focused on drug discovery in focused therapy areas such as cancer and anti-inflammatory treatments. The company considers merger and acquisition investment as a potential component of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities. It derives maximum revenue from India and also has its presence in other countries.
44GF Score

Get the complete analysis for BOM:532872

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹235.25
Price
₹83.76
GF Value